Setipiprant for androgenetic alopecia in males: Results from a randomized, double-blind, placebo-controlled phase 2a trial
Clinical, Cosmetic and Investigational Dermatology | Oct 21, 2021
Clinical, Cosmetic and Investigational Dermatology | Oct 21, 2021